Poster

Unlocking The Potential Of Viral Vectors Through Functional Titer Assays

By Leyla Diaz, Ph.D. and Nikolay Korokhov, Ph.D., MilliporeSigma

iStock-1166057429-viral-vector-vaccine-cell

Based on the unique nature of virus vectors used for gene-based therapies, careful design and often customization of test methods is necessary. In this presentation, we discuss two virus-based gene delivery platforms – adenoassociated virus (AAV) and lentivirus (LV) – focusing on the development, validation, and implementation of titration methods used to measure functional titer. We will review factors to consider for method selection and discuss strategies to accelerate method development and validation.

VIEW THE POSTER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of ? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.